Please note: In October and November 2010, the MHRA moved from its Market Towers address to a new location on Buckingham Palace Road. Please go to the contact us section of the website for updated contact details.
In this issue
Drug safety advice
- Saquinavir: effects on QT and PR interval prolongation
- Calcium gluconate injection in small-volume glass containers: new contraindications due to aluminium exposure risk*
Stop press
- Modafinil: European Medicines Agency recommends restricted use
- Rosiglitazone: current advice on cardiovascular risk
- Topical ketoprofen: reminder on risk of photosensitivity reactions
*Please note that in this article small volume refers to the licensed ampoules which are 10 mL
Drug Safety Update: Volume 4, Issue 1, August 2010 
